A3907, a novel orally bioavailable inhibitor of the apical sodium-dependent bile acid transporter, improves liver injury in a mouse model of cholestatic liver disease
JOURNAL OF HEPATOLOGY(2021)
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要
JOURNAL OF HEPATOLOGY(2021)